Moneycontrol PRO
HomeNewsBusinessPipeline Check: Here are the blockbuster drugs lined up by Indian drugmakers for US launch

Pipeline Check: Here are the blockbuster drugs lined up by Indian drugmakers for US launch

Cipla is rolling out plans to launch a generic of Advair while Lupin has got approval for Spiriva

July 05, 2023 / 17:26 IST
Respiratory and oncology segments are witnessing the maximum launch of complex drugs.
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts